Cryoport authorizes $100 million repurchase program

Management presenting at upcoming investor conferences nashville, tenn., march 11, 2022 /prnewswire/ -- cryoport, inc. (nasdaq: cyrx) ("cryoport" or the "company"), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced its board of directors has unanimously authorized a repurchase program, under which cryoport may repurchase up to $100 million of its outstanding common stock and/or convertible senior notes.
CYRX Ratings Summary
CYRX Quant Ranking